The U.S. Food and Drug Administration (FDA) issued a constituent update to the dietary supplement industry that signals the agency's intent to amend the labeling regulation that currently calls for ...
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback